Surgery Partners, Inc. (SGRY) Gain Loss Related To Litigation Settlement — Quarterly & Annual

Screener

Gain Loss Related To Litigation Settlement at other companies

First BanCorpFBP

$0—

ViatrisVTRS

-$73.2M-254%

Universal ElectronicsUEIC

$0+100%

NetgearNTGR

$1K+101%

Surgery Partners, Inc.SGRY

$0—

Riot Platforms, Inc.RIOT

$26.01M—

Other financials

Income statement

Revenue$848.9M+2.7%

Operating income$102.1M-8.6%

Net income-$15.0M-500%

EPS (diluted)-$0.12-500%

Balance sheet

Cash & equivalents$216.7M-13.4%

Total debt$5.1B+3.9%

Total equity$1.7B-4.4%

Total assets$8.0B+1.2%

Cash flow

Operating cash flow$59.3M-27.1%

CapEx$21.8M-6.8%

Free cash flow$37.5M-35.2%

Valuation

Market cap$2.03B-30.3%

Enterprise value$6.89B-8.7%

P/S0.6×-0.3×

Profitability

Gross margin23.1%—

Operating margin11.4%+0.2pp

Net margin-2.6%-0.9pp

FCF margin5.6%+0.2pp

Returns & leverage

Return on equity-5.2%-1.7pp

Debt / equity3×+0.2×

Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossRelatedToLitigationSettlement.

The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026. Open the filing →

Filed: Aug 10, 2026, 4:14 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001638833-26-000077

FAQ

What is Surgery Partners, Inc.'s gain loss related to litigation settlement?: Surgery Partners, Inc. (SGRY) reported gain loss related to litigation settlement of $0 in Q2 2026.
What does gain loss related to litigation settlement mean?: Gain Loss Related To Litigation Settlement as reported by Surgery Partners, Inc. Common Stock.

Ask your AI about Surgery Partners, Inc.'s gain loss related to litigation settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk